PlainRecalls
FDA Drug Moderate Class II Terminated

Daptomycin for Injection 500 mg per vial, Single-dose vial, Rx only, Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA. NDC 16729-435-05 UPC 3 16729 43505 5.

Reported: March 8, 2023 Initiated: February 7, 2023 #D-0382-2023

Product Description

Daptomycin for Injection 500 mg per vial, Single-dose vial, Rx only, Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA. NDC 16729-435-05 UPC 3 16729 43505 5.

Reason for Recall

CGMP Deviations: recalling drug products following an FDA inspection.

Details

Recalling Firm
Accord Healthcare, Inc.
Units Affected
228,760 vials
Distribution
United States including Puerto Rico and Canada
Location
Durham, NC

Frequently Asked Questions

What product was recalled?
Daptomycin for Injection 500 mg per vial, Single-dose vial, Rx only, Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA. NDC 16729-435-05 UPC 3 16729 43505 5.. Recalled by Accord Healthcare, Inc.. Units affected: 228,760 vials.
Why was this product recalled?
CGMP Deviations: recalling drug products following an FDA inspection.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 8, 2023. Severity: Moderate. Recall number: D-0382-2023.